About UsNewsShop
Fighting hereditary breast and ovarian cancer
Information & Research
| More

Issues for People at Risk

  • Basics

Attitudes of high-risk women toward preimplantation genetic diagnosis
Researchers from Moffitt Cancer Center in Tampa teamed up with FORCE to survey FORCE members about their knowledge of and attitudes about PGD.

Discussion of Challenges, Concerns, and Preliminary Policy Options Related to the Genetic Testing of Human Embryos
Published by the Genetics and Public Policy Center, this article presents the difficult and complex issues associated with Pre-implantation Genetic Diagnosis in a balanced and easy-to-read format.

Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
Kutluk Oktay, Ja Yeon Kim, David Barad, Samir N. Babayev. Journal of Clinical Oncology, Vol 28, No 2 (January 10), 2010: pages. 240-244.

Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer
Usha Menon. Human Reproduction, 2007; Vol. 22, No. 6: pages 1573-1577.

Cancer Genetic Testing and Assisted Reproduction
Kenneth Offit, Kelly Kohut, Bartholt Clagett, Eve A. Wadsworth, Kelly J. Lafaro, Shelly Cummings, Melody White, Michal Sagi, Donna Bernstein, Jessica G. Davis. Journal of Clinical Oncology, 2006; Vol . 24, No. 29; pages 4775-4782.


Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.

Privacy Policy | Sitemap | Contact Us

Morphtek

This site has been made possible by a generous grant from Morphotek.


Web design by Rareheron Web Design

copyright © FORCE: Facing Our Risk of Cancer Empowered, Inc.  •  info@facingourrisk.org